User login
“The Matrix” is more than a movie. It’s also part of the May 3 Vascular Research Initiatives Conference in Minneapolis, Minn.
“Matrix Revolution: Vascular Repair and Regeneration,” is the title of the Translational Panel at VRIC, to be moderated by SVS President Ronald Fairman, MD. Christopher K. Breuer, MD, will speak on “Development of Tissue Engineered Grafts for Use in Congenital Heart Surgery” and Jeffrey Lawson will discuss “Human Tissue Engineered Blood Vessels: Clinical Experience in Dialysis Access and Arterial Disease.” 
William Sessa, PhD, will deliver the keynote address, now known as the Alexander W. Clowes Distinguished Lecture.
VRIC, emphasizing vascular biology, is held the day before the American Heart Association’s Arteriosclerosis, Thrombosis and Vascular Biology Scientific Sessions. Both meetings will be at the Hyatt Regency Minneapolis. For more, visit vsweb.org/VRIC17.
“The Matrix” is more than a movie. It’s also part of the May 3 Vascular Research Initiatives Conference in Minneapolis, Minn.
“Matrix Revolution: Vascular Repair and Regeneration,” is the title of the Translational Panel at VRIC, to be moderated by SVS President Ronald Fairman, MD. Christopher K. Breuer, MD, will speak on “Development of Tissue Engineered Grafts for Use in Congenital Heart Surgery” and Jeffrey Lawson will discuss “Human Tissue Engineered Blood Vessels: Clinical Experience in Dialysis Access and Arterial Disease.”
William Sessa, PhD, will deliver the keynote address, now known as the Alexander W. Clowes Distinguished Lecture.
VRIC, emphasizing vascular biology, is held the day before the American Heart Association’s Arteriosclerosis, Thrombosis and Vascular Biology Scientific Sessions. Both meetings will be at the Hyatt Regency Minneapolis. For more, visit vsweb.org/VRIC17.
“The Matrix” is more than a movie. It’s also part of the May 3 Vascular Research Initiatives Conference in Minneapolis, Minn.
“Matrix Revolution: Vascular Repair and Regeneration,” is the title of the Translational Panel at VRIC, to be moderated by SVS President Ronald Fairman, MD. Christopher K. Breuer, MD, will speak on “Development of Tissue Engineered Grafts for Use in Congenital Heart Surgery” and Jeffrey Lawson will discuss “Human Tissue Engineered Blood Vessels: Clinical Experience in Dialysis Access and Arterial Disease.”
William Sessa, PhD, will deliver the keynote address, now known as the Alexander W. Clowes Distinguished Lecture.
VRIC, emphasizing vascular biology, is held the day before the American Heart Association’s Arteriosclerosis, Thrombosis and Vascular Biology Scientific Sessions. Both meetings will be at the Hyatt Regency Minneapolis. For more, visit vsweb.org/VRIC17.